How Research into Vitamin E shows promise
In Alzheimer's, as in aging generally, there is an increase in free radical formation. Vitamin E is an antioxidant thought to protect neurons by reducing free radical formation and preventing cell injury. Free radicals occur as a result of a normal cell function called 'oxidative metabolism'. Free radicals are highly reactive. They attack other cells, damage cell walls, DNA, as well as metabolic processes.
Significant Research into Vitamin E
Research from the Alzheimer's Cooperative Society reported in 1997 their findings on the effectiveness of vitamin E and Selegiline. Focusing on functional loss, the results suggested both vitamin E and Selegiline delayed nursing home placement, death and disability but not cognitive functions (as scored in memory and thinking tests). The researchers found no differences between combined use of vitamin E and Selegiline or from groups of participants receiving the individual substances. Dosages used in the study were 10 mg of selegiline once daily and/or 1,000 IU of vitamin E twice daily.
It is clear more research is required into the use of vitamin E.
Updated November 2005